Compagnie Lombard Odier SCmA’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,000	Closed	-$392K	–	580
2019 Q3	$392K	Hold	14,000	–	–	0.02%	196
2019 Q2	$199K	Hold	14,000	–	–	0.01%	247
2019 Q1	$125K	Hold	14,000	–	–	0.01%	323
2018 Q4	$106K	Buy	+14,000	New	+$225K	﹤0.01%	325

Compagnie Lombard Odier SCmA's DOVA Position: Q4 2019 in Review

Compagnie Lombard Odier SCmA sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 14,000 shares — an estimated $392K sold.

Compagnie Lombard Odier SCmA first reported a position in DOVA in Q4 2018 and held it in 4 quarters. The position peaked at $392K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Compagnie Lombard Odier SCmA reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 14,000 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $392K.
Compagnie Lombard Odier SCmA first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
Compagnie Lombard Odier SCmA's Dova Pharmaceuticals, Inc. Common Stock position peaked at $392K in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2019, filed 13 Feb 2020.